Daré Bioscience, Inc. (DARE)

Daré Bioscience Statistics

Total Valuation

Daré Bioscience has a market cap or net worth of $25.06 million. The enterprise value is $19.72 million.

Market Cap	25.06M
Enterprise Value	19.72M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Daré Bioscience has 8.70 million shares outstanding. The number of shares has increased by 16.29% in one year.

Current Share Class	8.70M
Shares Outstanding	8.70M
Shares Change (YoY)	+16.29%
Shares Change (QoQ)	+0.69%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	8.93%
Float	8.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.73
Forward PS	7.84
PB Ratio	-16.88
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.14

Current Ratio	1.14
Quick Ratio	0.89
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-66.79%
Return on Invested Capital (ROIC)	-1,243.91%
Return on Capital Employed (ROCE)	-469.80%
Revenue Per Employee	$72,358
Profits Per Employee	-$138,645
Employee Count	26
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.28% in the last 52 weeks. The beta is 1.38, so Daré Bioscience's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	-56.28%
50-Day Moving Average	3.07
200-Day Moving Average	3.45
Relative Strength Index (RSI)	39.32
Average Volume (20 Days)	18,768

Short Selling Information

The latest short interest is 87,442, so 1.01% of the outstanding shares have been sold short.

Short Interest	87,442
Short Previous Month	71,539
Short % of Shares Out	1.01%
Short % of Float	1.02%
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, Daré Bioscience had revenue of $1.88 million and -$3.60 million in losses. Loss per share was -$0.43.

Revenue	1.88M
Gross Profit	-19.76M
Operating Income	-23.03M
Pretax Income	-28.87M
Net Income	-3.60M
EBITDA	-22.99M
EBIT	-23.03M
Loss Per Share	-$0.43

Balance Sheet

The company has $11.23 million in cash and $5.89 million in debt, giving a net cash position of $5.34 million or $0.61 per share.

Cash & Cash Equivalents	11.23M
Total Debt	5.89M
Net Cash	5.34M
Net Cash Per Share	$0.61
Equity (Book Value)	-1.48M
Book Value Per Share	-0.17
Working Capital	1.79M

Cash Flow

In the last 12 months, operating cash flow was -$8.01 million and capital expenditures -$617,528, giving a free cash flow of -$8.63 million.

Operating Cash Flow	-8.01M
Capital Expenditures	-617,528
Free Cash Flow	-8.63M
FCF Per Share	-$0.99

Margins

Gross Margin	n/a
Operating Margin	-1,224.40%
Pretax Margin	-191.61%
Profit Margin	-191.61%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Daré Bioscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.29%
Shareholder Yield	n/a
Earnings Yield	-14.39%
FCF Yield	-34.44%

Analyst Forecast

The average price target for Daré Bioscience is $20.33, which is 605.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.33
Price Target Difference	605.90%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	134.46%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 1, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jul 1, 2024
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

Daré Bioscience has an Altman Z-Score of -16.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.02
Piotroski F-Score	3